Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 6Not yet recruiting 3Unknown 2Active not recruiting 2

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3Head & Neck 1

Conditions

Carcinoma, Hepatocellular 4Stomach Neoplasms 3Esophageal Squamous Cell Carcinoma 3Esophageal Neoplasms 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Spinocerebellar Degenerations 2Recurrence 2Rectal Neoplasms 2Neoplasms 2Gastric / Gastroesophageal Junction Adenocarcinoma 2EBV-associated Tumors 2Carcinoma, Non-Small-Cell Lung 2Vascular Complications 1Solid Tumors 1Solid Cancers 1Small Cell Lung Carcinoma 1Pathologic Complete Response 1Pancreatic Neoplasms 1Pancreatic Cancer Metastatic 1Oropharyngeal Neoplasms 1Nasopharyngeal Cancinoma (NPC) 1Mouth Neoplasms 1Melanoma 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell 1Locally Advanced Rectal Cancer 1Hypersensitivity 1Head and Neck Neoplasms 1Gynecologic Cancers 1

Interventions

tislelizumab 7Paclitaxel 5Radiotherapy 4Oxaliplatin 3Immune Checkpoint Inhibitors 3Carboplatin 3nedaplatin 2Radiation 2Leucovorin 2Fluorouracil 2Drug Therapy 2Cisplatin 2Albumin-Bound Paclitaxel 2tranilast 1toripalimab 1sintilimab 1irinotecan sucrosofate 1camrelizumab 1apatinib 1anlotinib 1Surgical Procedures, Operative 1Specimen Handling 1S 1 (combination) 1Robotic Surgical Procedures 1Radiosurgery 1Pemetrexed 1Patient Reported Outcome Measures 1Observation 1Nutrition Therapy 1Neoadjuvant Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Esophageal Neoplasms × Immune Checkpoint Inhibitors × Clear all
NCT07154108 2025-09-04

Endostatin Adenovirus With Checkpoint Inhibitor in Advanced Head and Neck or Esophageal Cancer

Sichuan University

Phase 1 Not yet recruiting
40 enrolled
GastrointestinalHead & Neck

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Head and Neck Neoplasms

NCT07034118 2025-06-24

Definitive Proton Radiotherapy Combined With Chemotherapy and Immunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase I Clinical Study

Anhui Provincial Hospital

Phase 1 Not yet recruiting
23 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT06889402 2025-03-21

Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Not yet recruiting
600 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Pathologic Complete Response, Esophageal Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡